XBRANE — Xbrane Biopharma AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK218.10m
- SEK314.32m
- SEK238.73m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -166 | -226 | -188 | -173 | -388 |
Depreciation | |||||
Non-Cash Items | 17.4 | -0.319 | -6.35 | 9.27 | 101 |
Discontinued Operations | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -7.27 | -18.6 | -38.4 | -30.7 | -119 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -149 | -238 | -220 | -194 | -406 |
Capital Expenditures | -1.19 | -3.85 | -77.3 | -60.1 | -16.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -1.19 | -3.85 | -77.3 | -60.1 | -16.8 |
Financing Cash Flow Items | -33.4 | -20.6 | -24.2 | -13.3 | -0.963 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 216 | 323 | 349 | 149 | 299 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 63.2 | 78.9 | 53.3 | -101 | -129 |